Salarius Pharmaceuticals Inc (NASDAQ:SLRX) Stock Boosted By Q1 Earnings

May 13, 2022

This morning the price action in the Salarius Pharmaceuticals Inc (NASDAQ:SLRX) stock could be of interest to many investors. Although the stock had managed to clock gains of as much as 39% on Thursday, it should be noted that it suffered from a heavy selloff in premarket trading and went down by as much as 18%. Trading Data On Thursday, SLRX stock surged 39% to $0.2220 with more than 12.85…


Salarius Pharmaceuticals Inc (NASDAQ:SLRX) Stock Takes a Hit After Disappointing Quarterly Earnings

March 14, 2022

This past Friday, the Salarius Pharmaceuticals Inc (NASDAQ:SLRX) stock had emerged as one of the major losers and ended the day with a decline of as much as 27%. It is a biopharmaceutical company and is primarily involved in the development of therapies for patients who may be in need to new options as regards their treatment. Trading Data On Friday, SLRX stock moved down 26.62% to $0.3669 with more…